2024 HERO Appendix B: NASA Human Research Program Omnibus Opportunity | 80JSC024NA001 OMNIBUS

Opportunity Information: Apply for 80JSC024NA001 OMNIBUS

The 2024 HERO Appendix B: NASA Human Research Program Omnibus Opportunity is a NASA Research Announcement (NRA 80JSC024NA001-OMNIBUS) issued by the NASA Johnson Space Center under the broader Human Exploration Research Opportunities (HERO) umbrella (80JSC024NA001). This appendix is designed to fund applied, near-term research that supports NASA's Human Research Program (HRP) goals, with a strong focus on producing practical results that can help reduce risk to astronauts and improve the safety and effectiveness of human spaceflight.

At its core, NASA is seeking one-year (or shorter) investigations that bring innovative approaches to specific human health and performance risks and research gaps identified by HRP. Those needs are documented in the HRP Integrated Research Plan, which is maintained on the Human Research Roadmap website (https://humanresearchroadmap.nasa.gov). In other words, proposed projects are expected to connect clearly to known issues affecting humans in space, such as health, physiology, behavioral health, performance, and operational concerns, as captured in the Roadmap's risk and gap structure.

In addition to projects that directly map to HRP-defined risks, the Omnibus opportunity also explicitly welcomes novel, outside-the-box ideas that may not align perfectly with existing HRP risk statements, as long as they are compelling and relevant to human spaceflight challenges. This "open door" is especially aimed at bringing in new investigators and early career investigators who have not been funded by NASA HRP, NASA EPSCoR, the National Space Biomedical Research Institute, or the Translational Research Institute for Space Health within the past ten years. For early career status, applicants must also be within ten years of their terminal research degree or completion of clinical training (with the solicitation providing the formal definitions and any exceptions).

From a funding and award standpoint, this is a discretionary opportunity that may be supported through several instrument types, including grants, cooperative agreements, and procurement contracts. The posted award ceiling is $150,000, and NASA anticipates making about three awards under this appendix (as listed in the opportunity record). The CFDA number associated with the program is 43.007, reflecting NASA research and development assistance.

Eligibility is broad: all categories of U.S. institutions may apply, described as unrestricted eligibility subject to any clarifications in the full text. Proposals may be led by universities and can include collaborations with federal laboratories, private-sector partners, and state or local government labs. The key administrative point is that the submitting organization remains responsible for overall project management and award administration in line with the management plan presented in the proposal. NASA also notes its policy regarding international participation: NASA may conduct research with non-U.S. organizations on a cooperative basis with no exchange of funds, meaning international partners can contribute, but NASA generally will not pay foreign entities under this arrangement.

The application process uses a two-step submission structure. A virtual pre-proposers conference was scheduled for October 16, 2023, to help potential applicants understand expectations and logistics. Step 1 proposals for Appendix B were due November 1, 2023, and only applicants invited forward would submit Step 2 proposals, due January 30, 2024. The appendix documentation and instructions are provided through the HERO Appendix B page (https://tinyurl.com/HERO24-OMNIBUS), and the overall HERO NRA with all open appendices is available via NASA Research Opportunities (https://tinyurl.com/HERO24OVERVIEW), with additional posting and submission details available through NSPIRES.

• The National Aeronautics and Space Administration, NASA Johnson Space Center in the science and technology and other research and development sector is offering a public funding opportunity titled "2024 HERO Appendix B: NASA Human Research Program Omnibus Opportunity" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 43.007.
• This funding opportunity was created on Oct 03, 2023.
• Applicants must submit their applications by Nov 01, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $150,000.00 in funding.
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for 80JSC024NA001 OMNIBUS

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: